| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e19c12ac350fc1c0c02bcf301685e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2011-12-07^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-10-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e6e2cd55722ddd094d84244ed60055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ea1c1e5593dd49343280e57fc1d2987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_902a3bf2cf0f19d169ab0f3a1bf3dfb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_269d7c1b8692bc90833fef104df39cc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69cd45049e3d28b7841cf8e17404f115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb026c706f58f67b23db0111c8ad8031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72ad980581582d8603a740a12d903012 |
| publicationDate |
2017-10-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2638602-T3 |
| titleOfInvention |
Procedure and kit for in vitro diagnosis of prostate cancer |
| abstract |
Procedure for the in vitro diagnosis of prostate cancer according to which a urine sample to be analyzed is contacted with two antibodies, a capture antibody and a detection antibody, one of the two antibodies is directed against the first repeated domain of native human annexin A3 whose sequence is identified as SEQ ID No. 1, and the other of the two antibodies is directed against the fourth repeated domain of native human annexin A3 whose sequence is identified as SEQ ID No. 2. |
| priorityDate |
2010-12-08^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |